訊映

+0.35 (+2.36%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

15.15349成交張數8.81本益比0.85股價淨值比1.98%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度	單季 EPS	年增	近四季 EPS	歸屬母公司淨利(億)	淨利率	ROE(季)	ROE(近四季)
2026Q2	0.35	–	1.72	0.48	11.0%	1.91%	9.90%
2026Q1	0.39	129.4%	0.80	0.55	14.4%	2.20%	4.52%
2025Q4	0.38	35.7%	0.58	0.54	15.9%	2.15%	3.29%
2025Q3	0.60	–	0.48	0.85	22.4%	3.52%	2.80%
2025Q2	-0.57	-290.0%	-0.29	-0.81	-19.0%	-3.34%	-1.68%
2025Q1	0.17	-32.0%	0.58	0.25	6.0%	1.00%	3.37%
2024Q4	0.28	–	0.66	0.40	9.5%	1.61%	3.84%
2024Q3	-0.17	-6396.3%	0.13	-0.24	-5.3%	-0.99%	0.96%
2024Q2	0.30	180.6%	0.30	0.42	9.6%	1.73%	2.09%
2024Q1	0.25	55.9%	0.11	0.36	10.3%	1.50%	0.90%
2023Q4	-0.25	–	0.02	-0.31	-11.2%	-1.29%	0.14%
2023Q3	0.00	-99.4%	0.22	0.01	0.3%	0.04%	1.38%
2023Q2	0.11	-79.0%	0.64	0.15	4.7%	0.69%	3.84%
2023Q1	0.16	-65.4%	1.04	0.18	5.6%	0.88%	5.69%
2022Q4	-0.05	–	1.35	-0.05	-1.7%	-0.30%	8.08%
2022Q3	0.43	182.3%	1.38	0.46	15.0%	2.67%	8.52%
2022Q2	0.51	–	1.11	0.54	12.3%	3.13%	6.92%
2022Q1	0.46	62.5%	0.59	0.49	11.7%	2.84%	3.71%
2021Q4	-0.02	-105.1%	0.41	-0.01	-0.4%	-0.08%	2.53%
2021Q3	0.15	-41.4%	0.78	0.15	5.0%	0.91%	4.76%
2021Q2	-0.01	-103.5%	0.88	-0.00	-0.1%	-0.01%	6.26%
2021Q1	0.29	-46.3%	1.14	0.30	10.1%	1.77%	7.84%
2020Q4	0.35	-9.3%	1.39	0.36	7.9%	2.09%	8.59%
2020Q3	0.26	-44.0%	1.43	0.26	7.7%	1.78%	8.91%
2020Q2	0.25	-16.9%	1.63	0.21	6.6%	1.67%	11.61%
2020Q1	0.53	56.4%	1.68	0.47	12.6%	3.69%	11.38%
2019Q4	0.38	-18.5%	1.49	0.33	8.9%	2.71%	9.91%
2019Q3	0.46	-20.9%	1.58	0.38	13.2%	3.34%	11.15%
2019Q2	0.30	0.0%	1.70	0.25	8.6%	2.08%	12.54%
2019Q1	0.34	-33.9%	1.70	0.29	10.3%	2.31%	11.73%
2018Q4	0.47	–	1.87	0.41	13.5%	3.29%	–
2018Q3	0.58	–	–	0.49	18.4%	4.11%	–
2018Q2	0.30	–	–	0.29	11.5%	2.43%	–
2018Q1	0.51	–	–	0.42	14.3%	–	–